¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"alpha blocker"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
alpha-blocker
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
axon blocker
Ãà»èÂ÷´ÜÁ¦
adrenergic blocker
¾Æµå·¹³¯¸°Â÷´ÜÁ¦
blocker
Â÷´Ü±â, Â÷´ÜÁ¦
calcium-channel blocker
Ä®½·Åë·ÎÂ÷´ÜÁ¦
neuromuscular blocker
½Å°æ±Ù(À°)Â÷´ÜÁ¦
receptor blocker
¼ö¿ëüÂ÷´ÜÁ¦
alpha emitter
¾ËÆÄ¹æÃâü
alpha error
¾ËÆÄ¿À·ù, Á¦1Çü¿À·ù
alpha granule
¾ËÆÄ°ú¸³
alpha hemolysis
¾ËÆÄ¿ëÇ÷
alpha motor neuron
¾ËÆÄ¿îµ¿½Å°æ¼¼Æ÷
alpha ray
¾ËÆÄ¼±
alpha wave
¾ËÆÄÆÄ
alpha-adrenergics
¾ËÆÄ¾Æµå·¹³¯¸°¼º¾à
alpha-chymotrypsin
¾ËÆÄŰ¸ðÆ®¸³½Å
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
blocker
Â÷´Ü±â, Â÷´ÜÁ¦
receptor blocker
¼ö¿ëüÂ÷´ÜÁ¦
alpha-interferon
¾ËÆÄÀÎÅÍÆä·Ð
alpha-adrenergics
¾ËÆÄ¾Æµå·¹³¯¸°¼º¾à
alpha-fetoprotein
¾ËÆÄžƴܹé
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
adrenergic blocker
¾Æµå·¹³¯¸°Â÷´ÜÁ¦
axon blocker
Ãà»èÂ÷´ÜÁ¦
blocker
Â÷´Ü±â, Â÷´ÜÁ¦
neuromuscular blocker
½Å°æ±ÙÀ°Â÷´ÜÁ¦
receptor blocker
¼ö¿ëüÂ÷´ÜÁ¦
alpha-chymotrypsin
¾ËÆÄÄ«ÀÌ¸ðÆ®¸³½Å
alpha-fetoprotein
¾ËÆÄžƴܹé
alpha-interferon
¾ËÆÄÀÎÅÍÆä·Ð
alpha-lipoproteinemia
¾ËÆÄÁö¹æ´Ü¹éÇ÷Áõ
alpha emitter
¾ËÆÄ¹æÃâ±â
alpha error
Á¦ÀÏÁ¾¿À·ù
alpha granule
¾ËÆÄ°ú¸³
alpha hemolysis
¾ËÆÄ¿ëÇ÷, ºÒ¿ÏÀü¿ëÇ÷
alpha ray
¾ËÆÄ¼±
alpha motor neuron
¾ËÆÄ¿îµ¿½Å°æ¼¼Æ÷
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
17-alpha-hydroxycorticosteroid
17-¾ËÆÄ-È÷µå·Ï½ÃÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å
17-alpha-hydroxyprogesterone
17-¾ËÆÄ-È÷µå·Ï½ÃÇÁ·Î°Ô½ºÅ×·Ð
alpha behavior
¾ËÆÄÇàÀ§
alpha blocking
¾ËÆÄÂ÷´Ü
alpha cell
¾ËÆÄ¼¼Æ÷
alpha cell
¾ËÆÄ¼¼Æ÷(¡á¬øà)
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
alpha cell tumor
¾ËÆÄ ¼¼Æ÷Á¾(¡á¬øàðþ)
alpha chain disease
¾ËÆÄ¼âº´(¡áðÜ»).
alpha chain disease
¾ËÆÄ¼âÁúȯ
alpha cradle
¾ËÆÄ¹Þħ´ë
alpha decay
¾ËÆÄºØ±«
alpha emitter
¾ËÆÄ¹æ»çü, ¾ËÆÄ¹æÃâü
alpha fetoprotein =AFP
¾ËÆÄžƴܹé(¡÷Ãä®Ó±ÛÜ).
alpha fiber
¾ËÆÄ(½Å°æ)¼¶À¯
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
beta blocker
º£Å¸ Â÷´ÜÁ¦( -ó´Ó¨ð¥)
beta blocker
º£Å¸ Â÷´ÜÁ¦(ó´Ó¨ð¥)
beta receptor blocker
º£Å¸¼ö¿ëü Â÷´ÜÁ¦( -áôé»ô÷ ó´Ó¨ð¥)
blocker
Â÷´Ü(ó´Ó¨).
blocker
Â÷´ÜÁ¦, Æó»ö¹°, ºÀ¼âÁ¦<¾à¹°>.
blocker/blocking agent
Â÷´ÜÁ¦
blocking antibody =blocker
Â÷´ÜÇ×ü(¡ù÷ô÷).
bronchial blocker
±â°üÁö Â÷´Ü¹°(Æó¼â¹°)
calcium channel antagonist,blocker
Ä®½·Åë·Î ±æÇ×Á¦( -÷×ÖØ ÑÏù÷ð¥),Â÷´ÜÁ¦(ó´Ó¨ð¥).
calcium channel blocker ; calcium channel blocking drug
Ä®½·Åë·ÎºÀ¼â¾à ¹°<Á¦>, Ä®½·Åë·Î Â÷´Ü¾à¹°<Á¦>.
calcium channel blocker ; calcium channel blocking drug
Ä®½·Åë·ÎºÀ¼â¾à¹°<Á¦>, Ä®½·Åë·ÎÂ÷´Ü¾à¹°<Á¦>.
cardioselective beta-adrenoreceptor blocker
½ÉÀå ¼±Åüº º£Å¸Â÷´ÜÁ¦(ãýíôàÔ÷Éàõ - ó´Ó¨ð¥)
depolarizing blocker
Â÷´ÜÁ¦(ó´Ó¨ð¥).
ion channel blocker
ÀÌ¿ÂÅë·ÎÂ÷´ÜÁ¦
neuromuscular blocker
½Å°æ±ÙÂ÷´Ü<ºÀ¼â>Á¦.
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½